Pancreatic acinar cell carcinoma
Clinical trials for Pancreatic acinar cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Pancreatic acinar cell carcinoma trials appear
Sign up with your email to follow new studies for Pancreatic acinar cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: targeted drug may delay return in BRCA patients
Disease control Recruiting nowThis phase II trial is testing whether the drug olaparib can help prevent pancreatic cancer from coming back in people who have already had surgery and chemotherapy and carry a BRCA1, BRCA2, or PALB2 mutation. Olaparib is a targeted therapy that blocks a repair enzyme cancer cell…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a genetic test choose the right chemo for pancreatic cancer?
Disease control Recruiting nowThis phase III trial tests whether a genetic signature can guide chemotherapy choice after surgery for pancreatic cancer. Patients are randomly assigned to receive either oxaliplatin-based or gemcitabine-based chemotherapy, chosen either by standard clinical criteria or by a tran…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase 3 • Sponsor: John Neoptolemos • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Experimental combo aims to overcome drug resistance in metastatic cancers
Disease control Recruiting nowThis early-stage trial is testing a combination of two chemotherapy drugs (melphalan and BCNU) plus vitamins B12b and C, followed by an infusion of the patient's own stem cells. The goal is to see if this approach is safe for people with metastatic pancreatic or breast cancer, es…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase 1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC